1.Electrode Position and the Clinical Outcome after Bilateral Subthalamic Nucleus Stimulation.
Sun Ha PAEK ; Jee Young LEE ; Han Joon KIM ; Daehee KANG ; Yong Hoon LIM ; Mi Ryoung KIM ; Cheolyoung KIM ; Beom Seok JEON ; Dong Gyu KIM
Journal of Korean Medical Science 2011;26(10):1344-1355
We compared the surgical outcome with electrode positions after bilateral subthalamic nucleus (STN) stimulation surgery for Parkinson's disease. Fifty-seven patients treated with bilateral STN stimulations were included in this study. Electrode positions were determined in the fused images of preoperative MRI and postoperative CT taken at six months after surgery. The patients were divided into three groups: group I, both electrodes in the STN; group II, only one electrode in the STN; group III, neither electrode in the STN. Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn and Yahr stage, and activities of daily living scores significantly improved at 6 and 12 months after STN stimulation in both group I and II. The off-time UPDRS III speech subscore significantly improved (1.6 +/- 0.7 at baseline vs 1.3 +/- 0.8 at 6 and 12 months, P < 0.01) with least L-dopa equivalent daily dose (LEDD) (844.6 +/- 364.1 mg/day at baseline; 279.4 +/- 274.6 mg/day at 6 months; and 276.0 +/- 301.6 mg/day at 12 months, P < 0.001) at 6 and 12 months after STN deep brain stimulation (DBS) in the group I. Our findings suggest that the better symptom relief including speech with a reduced LEDD is expected in the patients whose electrodes are accurately positioned in both STN.
Adult
;
Aged
;
Antiparkinson Agents/adverse effects/*therapeutic use
;
Combined Modality Therapy
;
*Deep Brain Stimulation/adverse effects/instrumentation/methods
;
*Electrodes, Implanted
;
Female
;
Humans
;
Levodopa/adverse effects/therapeutic use
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Parkinson Disease/drug therapy/*therapy
;
Severity of Illness Index
;
Subthalamic Nucleus/*physiology
;
Treatment Outcome
2.Influence of Propofol and Fentanyl on Deep Brain Stimulation of the Subthalamic Nucleus.
Wonki KIM ; In Ho SONG ; Yong Hoon LIM ; Mi Ryoung KIM ; Young Eun KIM ; Jae Ha HWANG ; In Keyoung KIM ; Sang Woo SONG ; Jin Wook KIM ; Woong Woo LEE ; Han Joon KIM ; Cheolyoung KIM ; Hee Chan KIM ; In Young KIM ; Hee Pyoung PARK ; Dong Gyu KIM ; Beom Seok JEON ; Sun Ha PAEK
Journal of Korean Medical Science 2014;29(9):1278-1286
We investigated the effect of propofol and fentanyl on microelectrode recording (MER) and its clinical applicability during subthalamic nucleus (STN) deep brain stimulation (DBS) surgery. We analyzed 8 patients with Parkinson's disease, underwent bilateral STN DBS with MER. Their left sides were done under awake and then their right sides were done with a continuous infusion of propofol and fentanyl under local anesthesia. The electrode position was evaluated by preoperative MRI and postoperative CT. The clinical outcomes were assessed at six months after surgery. We isolated single unit activities from the left and the right side MERs. There was no significant difference in the mean firing rate between the left side MERs (38.7+/-16.8 spikes/sec, n=78) and the right side MERs (35.5+/-17.2 spikes/sec, n=66). The bursting pattern of spikes was more frequently observed in the right STN than in the left STN. All the electrode positions were within the STNs on both sides and the off-time Unified Parkinson's Disease Rating Scale part III scores at six months after surgery decreased by 67% of the preoperative level. In this study, a continuous infusion of propofol and fentanyl did not significantly interfere with the MER signals from the STN. The results of this study suggest that propofol and fentanyl can be used for STN DBS in patients with advanced Parkinson's disease improving the overall experience of the patients.
Aged
;
Anesthetics, Intravenous/*pharmacology
;
*Deep Brain Stimulation
;
Electrodes, Implanted
;
Female
;
Fentanyl/*pharmacology
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Microelectrodes
;
Middle Aged
;
Parkinson Disease/*prevention & control
;
Propofol/*pharmacology
;
Severity of Illness Index
;
Subthalamic Nucleus/*drug effects/physiology
;
Tomography, X-Ray Computed